» Articles » PMID: 17311814

Ubiquitin-interaction Motifs of RAP80 Are Critical in Its Regulation of Estrogen Receptor Alpha

Overview
Specialty Biochemistry
Date 2007 Feb 22
PMID 17311814
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we demonstrate that receptor-associated protein 80 (RAP80) interacts with estrogen receptor alpha (ERalpha) in an agonist-dependent manner. The interaction is specific for ERalpha as ERbeta and several other nuclear receptors tested did not interact with RAP80. Interaction between RAP80 and ERalpha was supported by mammalian two-hybrid, GST pull-down, and co-immunoprecipitation analyses. The hinge/ligand-binding domain of ERalpha is sufficient for interaction with RAP80. RAP80 overexpression reduces ERalpha polyubiquitination, increases the level of ERalpha protein, and enhances ERalpha-mediated transactivation. Knockdown of endogenous RAP80 expression by small-interfering RNA (siRNA) reduced ERalpha protein level and the E2-dependent induction of pS2. In this study, we also demonstrate that RAP80 contains two functional ubiquitin-interaction motifs (UIMs) that are able to bind ubiquitin and to direct monoubiquitination of RAP80. Deletion of these UIMs does not affect the ability of RAP80 to interact with ERalpha, but eliminates the effects of RAP80 on ERalpha polyubiquitination, the level of ERalpha protein, and ERalpha-mediated transcription. These data indicate that the UIMs in RAP80 are critical for the function of RAP80. Our study identifies ERalpha as a new RAP80-interacting protein and suggests that RAP80 may be an important modulator of ERalpha activity.

Citing Articles

Exploring the Spatial Landscape of the Estrogen Receptor Proximal Proteome With Antibody-Based Proximity Labeling.

Rega C, Kozik Z, Yu L, Tsitsa I, Martin L, Choudhary J Mol Cell Proteomics. 2023; 23(1):100702.

PMID: 38122900 PMC: 10831774. DOI: 10.1016/j.mcpro.2023.100702.


Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPARγ for proteasomal degradation.

Dou H, Duan Y, Zhang X, Yu Q, Di Q, Song Y J Biol Chem. 2019; 294(48):18504-18515.

PMID: 31653699 PMC: 6885645. DOI: 10.1074/jbc.RA119.009282.


The Functions of DNA Damage Factor RNF8 in the Pathogenesis and Progression of Cancer.

Zhou T, Yi F, Wang Z, Guo Q, Liu J, Bai N Int J Biol Sci. 2019; 15(5):909-918.

PMID: 31182912 PMC: 6535783. DOI: 10.7150/ijbs.31972.


RAP80 expression in breast cancer and its relationship with apoptosis in breast cancer cells.

Jin G, Mao X, Qiao Z, Chen B, Jin F Onco Targets Ther. 2019; 12:625-634.

PMID: 30705591 PMC: 6343510. DOI: 10.2147/OTT.S186981.


Ubiquitin Ligase NEDD4 Regulates PPARγ Stability and Adipocyte Differentiation in 3T3-L1 Cells.

Li J, Wang R, Lama R, Wang X, Floyd Z, Park E Sci Rep. 2016; 6:38550.

PMID: 27917940 PMC: 5137149. DOI: 10.1038/srep38550.


References
1.
Chang C, Norris J, Gron H, Paige L, Hamilton P, Kenan D . Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta. Mol Cell Biol. 1999; 19(12):8226-39. PMC: 84907. DOI: 10.1128/MCB.19.12.8226. View

2.
Fernandes I, Bastien Y, Wai T, Nygard K, Lin R, Cormier O . Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol Cell. 2003; 11(1):139-50. DOI: 10.1016/s1097-2765(03)00014-5. View

3.
Ruff M, Gangloff M, Wurtz J, Moras D . Estrogen receptor transcription and transactivation: Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors. Breast Cancer Res. 2001; 2(5):353-9. PMC: 138657. DOI: 10.1186/bcr80. View

4.
Hewitt S, Korach K . Oestrogen receptor knockout mice: roles for oestrogen receptors alpha and beta in reproductive tissues. Reproduction. 2003; 125(2):143-9. DOI: 10.1530/rep.0.1250143. View

5.
Shih S, Prag G, Francis S, Sutanto M, Hurley J, Hicke L . A ubiquitin-binding motif required for intramolecular monoubiquitylation, the CUE domain. EMBO J. 2003; 22(6):1273-81. PMC: 151082. DOI: 10.1093/emboj/cdg140. View